Vast Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Vast Therapeutics?

Vast Therapeutics has 4 investors including National Institutes of Health And National Institutes of Health.

Q: When was the last funding round for Vast Therapeutics?

Vast Therapeutics closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Vast Therapeutics raised to date?

Vast Therapeutics has raised obfuscated.

Overview

Vast Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Vast Therapeutics

CB Rank

37438

Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .

Founded

obfuscation

Private

Grant

Morrisville, North Carolina, United States

1-10

vasttherapeutics.com/

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Grant

OBF

obfuscation

Equity Crowdfunding

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Paul Bruinenberg: Chief Medical Officer
Past Role: Tiara Pharmaceuticals, Interim CEO, CMO and Board member
John Oakley: CFO
Past Role: Cleaver-Brooks, Chief Financial Officer

Details

Legal Name

Vast Therapeutics, Inc

Also Known As

Novoclem

Operating Status

Active

Company Type

For Profit

Founders

Mark Schoenfisch

About the Company

Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the preclinical stage of developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.

Phone Number

919-321-1375

Contact Email

info@vasttherapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Vast Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

ALX1 Drug Candidate

A nitric oxide prodrug formulated as an inhaled aqueous solution releasing nitric oxide over up to 8 hours to target lung infections and inflammation.

Nitric Oxide Prodrugs

A portfolio of inhaled nitric oxide-releasing prodrugs with variable release durations designed to treat severe respiratory infections and inflammation.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - Vast Therapeutics	1	obfuscated obfuscation	National Institutes of Health	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institutes of Health	Yes	Grant - Vast Therapeutics	—
National Institutes of Health	Yes	Grant - Vast Therapeutics	—
National Institutes of Health	Yes	Grant - Vast Therapeutics	—
National Institutes of Health	Yes	Grant - Vast Therapeutics	—
National Institutes of Health	Yes	Grant - Vast Therapeutics	—